source
- FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with NovoEli Lilly’s once-weekly basal insulin shot Onswik has been approved by the FDA for patients with type 2 diabetes. Lilly has touted Onswik as a longer-acting alternative to daily basal insulin injec…Endpoints · 1mo ago↗ source
- FDA nominee Heidi Overton pledges faster drug trials to keep US biotech competitiveHeidi Overton, President Trump's nominee for FDA commissioner, will appear before a Senate committee to outline her priorities for the agency. She said the administration wants her to 'go fast,' a…